Non-invasive shockwave therapy that accelerates healing and boosts practice success—trusted by top providers nationwide. This page is for providers.
If you are a patient seeking treatment please visit https://softwavetrt.com/providers/ SoftWave TRT, LLC is a medical technology company that is developing advanced solutions specializing in shockwave therapy for better patient healing.
Founded in 2004 and headquartered in Alpharetta, GA, SoftWave TRT is committed to the scientific advancement of tissue healing and regeneration and the development of the most effective innovations to improve the quality of lives globally. German-engineered with superior quality, it is used worldwide in the healthcare fields of orthopedics, traumatology, wound care, aesthetics, and urology. SoftWave technology is trusted by the top major medical research centers in the U.S. and worldwide, with over 300 published studies of the technology supporting its effectiveness. It has a strong international presence with its German manufacturing partner and is internationally recognized by the International Society for Medical Shockwave Technology (ISMST).
12/20/2025
A golf cart accident.
A nearly severed foot.
A career that almost ended.
Then Dr. Mark LeVee discovered SoftWave — and it changed everything.
Today, he doesn’t just use the technology. He’s dedicated his career to helping others heal with it.
12/17/2025
This visual is a simulation of the SoftWave focal zone.
It shows the width and depth of the focal zone beneath the surface, providing context for the area in which energy is focused during a session.
Because this process happens out of sight, visual simulations can be a helpful way to better understand what’s being represented.
12/10/2025
He’s tried a lot of technologies in his career — but nothing compares to this. SoftWave is helping his patients feel relief right away, without side effects, and it’s become one of the most valuable tools in his practice.
12/08/2025
The details matter.🔍
Dual-geometry reflectors. SmartTrode® technology. German engineering.
SoftWave isn’t just a device — it’s a biological signal delivery system designed to activate natural repair and support better patient outcomes.
12/02/2025
What makes SoftWave different from other shockwave technologies?
➤ Increases blood flow
➤ Activates endogenous stem cells
➤ Modulates inflammation
➤ Supports long-term tissue repair
➤ Non-invasive with no downtime for patients
SoftWave’s broad-focused, electrohydraulic technology allows providers to treat more tissue, more effectively — and see faster clinical outcomes.
Want to see how SoftWave fits into your practice workflow or specialty?
Reach out and our team can walk you through clinical use cases.
12/01/2025
Join Dr. Rikin Patel, DO and Dr. Sean Mulvaney, MD for a focused session on how shockwave therapy enhances tissue regeneration, modulates pain, and improves MSK outcomes.
Black Friday has arrived — and our strongest clinic package of the year is live.
Clinics across the country have already taken advantage of it, and it’s the ideal moment to explore if you’ve been considering SoftWave.
More financing flexibility. More protection. More momentum heading into 2026.💥
Today we’re giving thanks for the community behind SoftWave — the innovators, the providers, the caregivers, and the patients who make healing possible.
Wishing everyone a warm and restorative Thanksgiving. 🍁💙
11/26/2025
Black Friday arrived early this year — and clinics are jumping on it.
If SoftWave has been on your mind, this is your reminder: now is the time to take a look.
Be the first to know and let us send you an email when SoftWave TRT posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Tissue Regeneration Technologies (TRT) is a worldwide leader in medical shockwave technology. TRT manufactures and distributes various shockwave (ESWT) devices including the unfocused LithoGold lithotripter, UroGold, DermaGold, and OrthoGold. These medical devices are used in Urology, Orthopedics, Sports Medicine, Wound care, and Cardiology. In 2006, TRT has proven that its patented SoftWave technology has a strong regenerative effect on tissue including skin, bones, nerves, and heart.
The patented softwave technology uses various lens configurations to produce pressure waves. These waves have a characteristic pressure profile of short rise-times reaching high amplitudes (comparable to a sonic boom). The pressure waves can be shaped through a reflector, which enables the transmission of either highly-focused Shockwaves for use on urinary stones or non-union fractures, or soft-focused pressure waves (i.e., SoftWaves) for most soft tissue indications.
TRT’s patented SoftWave technology is distinguished from competitors’ shockwave technology in that TRT uses a patented parabolic (as opposed to an ellipsoid) reflector in the therapy head, which allows delivery of unfocused waves of acoustic energy over a broad target area. TRT’s SoftWave technology generates less pain, has a higher efficacy rate, and has a lower re-treatment rate than competitors’ high-energy, focused shockwave systems. TRT is the first company to discover that “softwaves” have the same or better clinical benefit as high-energy focused Shockwaves for most medical conditions. Following this discovery, TRT further developed the idea into a useful format, and secured patents protecting its inventions.
The advantages of SoftWave technology include the following benefits: (1) treatments do not require anesthesia; (2) larger surfaces, such as wounds, can be treated faster and easier than with competing shockwave devices.
TRT currently has product lines developed for the treatment of six distinct areas of care:
LithoGold – Lithotripsy and urology indications
OrthoGold – Orthopedic indications
DermaGold – Wound care indications
CardioGold – Cardiac and vascular indications
VetGold – Veterinary indications
UroGold – Urologic indications
The OrthoGold has been FDA cleared for connective tissue activation and registered for increased blood flow and pain relief. The DermaGold has been FDA cleared to treat diabetic ulcers.